Home / CDH23 Knockout Cell Lines

CDH23 Knockout Cell Lines

Gene: CDH23

Official Full Name: cadherin related 23provided by HGNC

Gene Summary: This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO18875 CDH23 Knockout cell line (HEK293) Human CDH23 1:3~1:6 Negative Online Inquiry
KO18876 CDH23 Knockout cell line (A549) Human CDH23 1:3~1:4 Negative Online Inquiry

Background

CDH23 Gene Knockout Cell Lines are genetically-engineered cell models specifically designed to study the functions and implications of the CDH23 gene, a key player in cellular adhesion and auditory functions. This product provides a vital tool for researchers investigating the molecular mechanisms underpinning auditory disorders and other cellular processes where CDH23 is implicated.

The key function of these knockout cell lines is to eliminate the expression of the CDH23 gene, which encodes the cadherin-related 23 protein. This protein is integral to the structure and function of hair cells in the inner ear, as it participates in cell-cell adhesion, signaling pathways, and maintaining the integrity of auditory structures. By observing changes in cellular behavior, morphology, and signaling in CDH23 knockout lines, researchers can unveil the gene’s role in hearing and non-auditory functions.

The scientific importance of CDH23 knockout cell lines is underscored by their applications in both basic research and translational medicine. They serve as definitive models for studying mechanisms of hereditary hearing loss—specifically, nonsyndromic forms of deafness—and can facilitate exploration into potential therapeutic avenues, including gene therapy and pharmacological interventions.

One of the product's distinctive advantages is its reliability and reproducibility in experimental setups, compared to other gene editing approaches that may introduce off-target effects or variability. Moreover, while alternatives may require labor-intensive creation and validation, our ready-to-use knockout cell lines save researchers valuable time, enabling more efficient experimentation.

For researchers and clinicians alike, the value of CDH23 Gene Knockout Cell Lines lies in their ability to provide accurate models that illuminate complex biological questions, ultimately driving forward the understanding of genetic contributions to auditory health. This innovative product is backed by our company’s extensive expertise in genetic engineering and cell line development, ensuring high-quality tools that support cutting-edge biological research.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.